
Medline Inc (MDLN) Stock Forecast & Price Target
Medline Inc (MDLN) Analyst Ratings
Bulls say
Medline is a leader in the medical-surgical space, with a high percentage of domestic revenue and strong relationships with major US health systems. The company's large product offering, manufacturing capabilities, and logistics network give it significant scale and competitive advantages. Forward-thinking initiatives such as incorporating AI into its supply chain and expanding internationally position Medline for continued growth and success in the future.
Bears say
Medline is a leading provider of medical-surgical products and supply chain solutions in the US, with strong customer demand and increasing AI-driven efficiencies driving accelerated revenue growth. However, recent post-Q1 report pullback and near-term tariffs and margin pressure have created a buying opportunity. With strong brands and a dominant market position, along with its expanding digital control-tower platform and warehouse automation partnership, Medline is well-positioned for long-term growth and margin expansion. Despite currently trading at a premium valuation, the company's multiple growth levers and competitive advantages justify a Buy rating and target price.
This aggregate rating is based on analysts' research of Medline Inc and is not a guaranteed prediction by Public.com or investment advice.
Medline Inc (MDLN) Analyst Forecast & Price Prediction
Start investing in Medline Inc (MDLN)
Order type
Buy in
Order amount
Est. shares
0 shares